XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Note 19 - Segment Reporting | 6 Months Ended
--- | ---
Dec. 31, 2023
Notes to Financial Statements |
Segment Reporting Disclosure [Text Block] | Note 19 - Segment Reporting The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, allocates resources and assesses performance based on the Company’s financial information. The CODM reviews financial information presented for each reportable segment for the purpose of making operating decisions and assessing financial performance. The Company manages and aggregates its operational and financial information in accordance with two reportable segments: Rx and Consumer Health. The Rx Segment consists of the Company’s prescription products. The Consumer Health Segment contains the Company’s consumer healthcare products. For purposes of determining operating income or loss by segment, the Company allocates common expenses such as corporate administration, executive and board compensation, insurance, and fees associated with being a publicly traded entity, among others, to the Rx Segment. The Rx Segment also includes pipeline research and development. The CODM does not regularly review asset information by segment, accordingly, asset information is not provided by segment. Select financial information for these segments is as follows:
|  | Rx |  |  | Consumer Health |  |  | Consolidated |
|  | (in thousands) |
Three Months Ended December 31, 2023 |  |  |  |  |  |  |  |  |  |  |  |
Product revenue, net |  | $ | 18,748 |  |  | $ | 4,186 |  |  | $ | 22,934 |
Income (loss) from operations |  | $ | 3,146 |  |  | $ | (782 | ) |  | $ | 2,364 |
Depreciation and amortization |  | $ | 1,510 |  |  | $ | 389 |  |  | $ | 1,899 |
Stock-based compensation expense |  | $ | 707 |  |  | $ | 113 |  |  | $ | 820 |
Three Months Ended December 31, 2022 |  |  |  |  |  |  |  |  |  |  |  |
Product revenue, net |  | $ | 18,029 |  |  | $ | 8,250 |  |  | $ | 26,279 |
Loss from operations |  | $ | (5,464 | ) |  | $ | (1,404 | ) |  | $ | (6,868 | )
Depreciation and amortization |  | $ | 1,572 |  |  | $ | 281 |  |  | $ | 1,853 |
Impairment expense |  | $ | 2,600 |  |  | $ | — |  |  | $ | 2,600 |
Stock-based compensation expense |  | $ | 2,987 |  |  | $ | 80 |  |  | $ | 3,067 |
|  | Rx |  |  | Consumer Health |  |  | Consolidated |
|  | (in thousands) |
Six Months Ended December 31, 2023 |  |  |  |  |  |  |  |  |  |  |  |
Product revenue, net |  | $ | 36,565 |  |  | $ | 8,468 |  |  | $ | 45,033 |
Income (loss) from operations |  | $ | 2,280 |  |  | $ | (1,420 | ) |  | $ | 860 |
Depreciation and amortization |  | $ | 3,064 |  |  | $ | 776 |  |  | $ | 3,840 |
Stock-based compensation expense |  | $ | 1,432 |  |  | $ | 318 |  |  | $ | 1,750 |
Six Months Ended December 31, 2022 |  |  |  |  |  |  |  |  |  |  |  |
Product revenue, net |  | $ | 36,681 |  |  | $ | 17,253 |  |  | $ | 53,934 |
Loss from operations |  | $ | (6,457 | ) |  | $ | (2,219 | ) |  | $ | (8,676 | )
Depreciation and amortization |  | $ | 3,146 |  |  | $ | 562 |  |  | $ | 3,708 |
Impairment expense |  | $ | 2,600 |  |  | $ | — |  |  | $ | 2,600 |
Stock-based compensation expense |  | $ | 4,149 |  |  | $ | 95 |  |  | $ | 4,244 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//280/tableOfContent Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration